ArticleCureus2025
Gianotti-Crosti Syndrome: A Rare Presentation of the Influenza Virus.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gianotti-Crosti Syndrome (GCS) is a benign, self-limited dermatologic condition that predominantly affects pediatric patients. It is most commonly associated with viral infections; however, reports implicating Influenza A virus (IAV) as an etiological agent are exceedingly rare. We report the case of a previously healthy two-year-old girl who presented with fever, rhinorrhea, and a symmetric papulovesicular rash involving the extremities, face, and trunk. Laboratory evaluation revealed leukopenia, neutropenia, and mildly elevated aspartate aminotransferase levels. Serological testing for Epstein-Barr virus (EBV), cytomegalovirus (CMV), and parvovirus B19 was negative, while antigen-based nasal swab testing confirmed the presence of IAV. Based on the characteristic clinical features and exclusion of other common causes, a diagnosis of GCS secondary to IAV infection was established. The patient received symptomatic treatment, and the rash resolved completely within 12 days, with no residual skin changes or complications. This case highlights a rare but clinically relevant association between IAV and GCS. Although cutaneous manifestations of IAV infection are uncommon, they should be considered in the differential diagnosis of GCS, particularly during influenza season. Prompt recognition of this condition is essential to avoid unnecessary investigations and to provide appropriate guidance and reassurance to caregivers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.